Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
![[11C]HSP990 in Alzheimer Disease: NCT07380204 Clinical Landscape Report 2026](https://synapse-static.patsnap.com/strapi-static/Blog_cover_B_86_48077a7b89.jpg)
9 min read
[11C]HSP990 in Alzheimer Disease: NCT07380204 Clinical Landscape Report 2026
16 September 2026
NCT07380204 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pociredir in Semicircular Canal Dehiscence: NCT07401823 Clinical Landscape Report 2026
16 September 2026
NCT07401823 clinical landscape for Semicircular Canal Dehiscence: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Universal allogeneic anti-CD19/BCMA CAR T-cells(Hematology Hospital of Chinese Academy of Medical Sciences) in Neuromyelitis Optica: NCT07392528 Clinical Landscape Report 2026
16 September 2026
NCT07392528 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Riluzole in Amyotrophic Lateral Sclerosis: NCT07414212 Clinical Landscape Report 2026
16 September 2026
NCT07414212 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ETX-312 in Metabolic Dysfunction Associated Steatohepatitis: ISRCTN65253349 Clinical Landscape Report 2026
16 September 2026
ISRCTN65253349 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Tranexamic Acid in Hemorrhage: NCT07392034 Clinical Landscape Report 2026
16 September 2026
NCT07392034 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CTx-1000 in Amyotrophic Lateral Sclerosis: NCT07401121 Clinical Landscape Report 2026
16 September 2026
NCT07401121 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SRN-001(siRNAgen Therapeutics) in Idiopathic Pulmonary Fibrosis: NCT07407543 Clinical Landscape Report 2026
16 September 2026
NCT07407543 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HN-2302 in Myasthenia Gravis: NCT07413835 Clinical Landscape Report 2026
16 September 2026
NCT07413835 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Pneumoconiosis: NCT07420439 Clinical Landscape Report 2026
16 September 2026
NCT07420439 clinical landscape for Pneumoconiosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NSC-706744 in Glioblastoma Multiforme: NCT07416188 Clinical Landscape Report 2026
16 September 2026
NCT07416188 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
nL-CHCHD-001 in Amyotrophic Lateral Sclerosis: NCT07423494 Clinical Landscape Report 2026
16 September 2026
NCT07423494 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.